Tiwari G, et al. Drug delivery systems: an updated review. Int J Pharm Investig. 2012;2(1):2–11.

Article  PubMed  PubMed Central  Google Scholar 

Kaur P, Khatik GL. Advancements in non-steroidal antiandrogens as potential therapeutic agents for the treatment of prostate cancer. Mini-Rev Med Chem. 2016;16(7):531–46.

Article  CAS  PubMed  Google Scholar 

Jyothi BJ, Sreelakshmi K. Design and evaluation of self-nanoemulsifying drug delivery system of Flutamide. J Young Pharm. 2011;3(1):4–8.

Elkhodairy KA, Hassan MA, Afifi SA. Formulation and optimization of orodispersible tablets of flutamide. Saudi Pharm J. 2014;22(1):53–61.

Article  PubMed  Google Scholar 

Newman A, Nagapudi K, Wenslow R. Amorphous solid dispersions: a robust platform to address bioavailability challenges. Ther Deliv. 2015;6(2):247–61.

Article  CAS  PubMed  Google Scholar 

Ashwathy P, Anto AT, Sudheesh MS. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions. Drug Dev Ind Pharm. 2021;47(1):1–11.

Article  CAS  PubMed  Google Scholar 

Singh A, Van den Mooter G. Spray drying formulation of amorphous solid dispersions. Adv Drug Deliv Rev. 2016;100:27–50.

Article  CAS  PubMed  Google Scholar 

Solanki NG, Kathawala M, Serajuddin ATM. Effects of surfactants on itraconazole-hydroxypropyl methylcellulose acetate succinate solid dispersion prepared by hot melt extrusion III: tableting of extrudates and drug release from tablets. J Pharm Sci. 2019;108(12):3859–69.

Article  PubMed  Google Scholar 

Ravikumar AA, et al. Carvedilol precipitation inhibition by the incorporation of polymeric precipitation inhibitors using a stable amorphous solid dispersion approach: formulation, characterization, and in vitro in vivo evaluation. Polymers (Basel). 2022;14(22).

Chavan RB, Lodagekar A, Shastri NR. Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions. Drug Dev Ind Pharm. 2018;44(12):1933–41.

Article  CAS  PubMed  Google Scholar 

Pandi P, et al. Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int J Pharm. 2020;586:119560.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munnangi SR, et al. Drug complexes: perspective from academic research and pharmaceutical market. Pharm Res. 2023;40(6):1519–40.

Article  CAS  PubMed  Google Scholar 

Liu M, et al. Supersaturation maintenance of carvedilol and chlorthalidone by cyclodextrin derivatives: pronounced crystallization inhibition ability of methylated cyclodextrin. Int J Pharm. 2023;637:122876.

Article  CAS  PubMed  Google Scholar 

Allahyari S, et al. Preparation and characterization of cyclodextrin nanosponges for bortezomib delivery. Expert Opin Drug Deliv. 2020;17(12):1807–16.

Article  CAS  PubMed  Google Scholar 

Palassi S, et al. Preparation and in vitro characterization of enoxaparin nano-liposomes through different methods. Adv Pharm Bull. 2021;11(2):295–300.

CAS  PubMed  Google Scholar 

Brahman PK, et al. Voltammetric determination of anticancer drug flutamide in surfactant media at polymer film modified carbon paste electrode. Colloids Surf A: Physicochem Eng. 2012;396:8–15.

Article  CAS  Google Scholar 

Mahmoudian M, Zakeri-Milani P, Valizadeh H. Investigating intestinal permeability of bortezomib using a validated HPLC-UV method. Drug Res (Stuttg). 2019;69(3):130–5.

Article  CAS  PubMed  Google Scholar 

Alsalhi MS, Royall PG, Chan KLA. Mechanistic study of the solubilization effect of basic amino acids on a poorly water-soluble drug. RSC Adv. 2022;12(30):19040–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alwossabi AM, et al. Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer. Saudi Pharm J. 2022;30(6):711–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dixit M, et al. A novel technique to enhancing the solubility and dissolution of flutamide using freeze drying. Turk J Pharm Sci. 2012;9:139–50.

CAS  Google Scholar 

Pacułt J, et al. How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions. Eur J Pharm Sci. 2021;159:105697.

Article  PubMed  Google Scholar 

Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig. 2012;2(1):12–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rawat S, Jain SK. Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexes. Eur J Pharm Biopharm. 2004;57(2):263–7.

Article  CAS  PubMed  Google Scholar 

Arul Gnana Dhas AS, et al. Intramolecular charge transfer effects on flutamide drug. J Fluoresc. 2010;20:809–820.

Sid D, et al. Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies. J Enzyme Inhib Med Chem. 2021;36(1):605–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allahyari S, et al. In-vitro characterization and cytotoxicity study of flutamide loaded cyclodextrin nanosponges. J Drug Deliv Sci Technol. 2021;61:102275.

Article  CAS  Google Scholar 

Nagarjuna G, Babu PK, Maruthi Y, Parandhama A, Madhavi C, Subha MC, Chowdojirao K. Interpenetrating polymer network hydrogel membranes of karayagum and sodium alginate for control release of flutamide drug. 2016;6(12):011–019.

Hiew TN, Zemlyanov DY, Taylor LS. Balancing solid-state stability and dissolution performance of lumefantrine amorphous solid dispersions: the role of polymer choice and drug–polymer interactions. Mol Pharmaceutics. 2022;19(2):392–413.

Article  CAS  Google Scholar 

Elgindy N, et al. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide. Eur J Pharm Biopharm. 2010;74(2):397–405.

Article  CAS  PubMed  Google Scholar 

Homayouni A, et al. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers. Iran J Basic Med Sci. 2014;17.

Sapkal S, et al. Solid dispersion of valsartan for solubility improvement using β-cyclodextrin. MOJ Bioequiv Availab. 2018;5:313–9.

Google Scholar 

Deshmane S. Behavioural study of cyclodextrin inclusion complex on enhancement of solubility of aceclofenac. Indian Drugs. 2015;52.

Qian F, Huang J, Hussain MA. Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development. J Pharm Sci. 2010;99(7):2941–7.

Article  CAS  PubMed  Google Scholar 

Zhang D, et al. Processing impact on performance of solid dispersions. Pharmaceutics. 2018;10(3).

Huang Y, Dai WG. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B. 2014;4(1):18–25.

Article  PubMed  Google Scholar 

Gala UH, et al. The effect of drug loading on the properties of abiraterone–hydroxypropyl beta cyclodextrin solid dispersions processed by solvent free KinetiSol® technology. Eur J Pharm Biopharm. 2021;165:52–65.

Article  CAS  PubMed  Google Scholar 

Saokham P, et al. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules. 2018;23(5).

Jansook P, Ogawa N, Loftsson T. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications. Int J Pharm. 2018;535(1):272–84.

Article  CAS  PubMed  Google Scholar 

Loftsson T, Saokham P, Couto AR. Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions. Int J Pharm. 2019;560:228–234.

Saokham P, et al. The self-assemble of natural cyclodextrins in aqueous solutions: application of miniature permeation studies for critical aggregation concentration (cac) determinations. Int J Pharm. 2016;505.

González-Gaitano G, et al. The aggregation of cyclodextrins as studied by photon correlation spectroscopy. J Incl Phenom Macrocycl Chem. 2002;44(1):101–5.

Article  Google Scholar 

Shi N-Q, Yao J, Wang X-L. Effect of polymers and media type on extending the dissolution of amorphous pioglitazone and inhibiting the recrystallization from a supersaturated state. Drug Dev Ind Pharm. 2014;40(8):1112–22.

Article  CAS  PubMed  Google Scholar 

Dias MMR, et al. The effect of β-cyclodextrins on the permeation of diclofenac from supersaturated solutions. Int J Pharm. 2003;263(1):173–81.

Article  CAS  PubMed  Google Scholar 

Semalty M, et al. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation. Curr Drug Discov Technol. 2014;11(2):154–61.

Article  CAS  PubMed  Google Scholar 

Trivino A, et al. Drug–polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide. Drug Dev Ind Pharm. 2019;45(8):1277–91.

Article  CAS  PubMed  Google Scholar 

Swami G, et al. Preparation and characterization of domperidone-?-cyclodextrin complexes prepared by kneading method. Int J Adv Pharm Sci. 2010;1(1).

Yuvaraja K, Khanam J. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid. J Pharm Biomed Anal. 2014;96:10–20.

Article  CAS  PubMed  Google Scholar